Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Pathology Associates Wrn 2
Boston, MA 02114Phone+1 617-726-2967Fax+1 617-726-7474
Summary
- Dr. Chin-Lee Wu is a pathologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He received his medical degree from Southern Medical University and has been in practice 34 years. He specializes in genitourinary pathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in genitourinary pathology. He has more than 200 publications and over 15000 citings.
Education & Training
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
Southern Medical UniversityClass of 1983
Certifications & Licensure
MA State Medical License 1998 - 2025- American Board of Pathology Anatomic Pathology
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 37 citationsGPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate.Jianjiang Xie, Jianheng Ye, Zhiduan Cai, Yong Luo, Xuejin Zhu
Cancer Research. 2020-06-01 - 28 citationsA HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.Ren Liu, Yuanfa Feng, Yulin Deng, Zhihao Zou, Jianheng Ye
Journal of Experimental & Clinical Cancer Research. 2021-06-07 - 10 citationsGenome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide levelYu Jin, Yi Zhou, Wen-feng Deng, Yuchen Wang, Richard T. Lee
Oncogene. 2021-01-07
Press Mentions
Gene-Expression Signature May Signify Risk for Recurrence, Metastasis in Prostate CancerApril 15th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
